Phaarmasia Ltd 523620.BO

₹89.35 ₹0.39 (0.43%) 1D

Last Updated: May 15, 12:00 AM·BSE

523620.BO Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: November 18, 2025

Report Source: 2026 2nd Quarter Report

Phaarmasia Ltd

Phaarmasia Ltd. Stock Analysis 523620.BO

India Health Care Nano Cap Report:
Phaarmasia Ltd. engages in the manufacture of pharmaceutical products. The company is headquartered in Hyderabad, Telangana. The firm manufactures and markets oral contraceptive tablets with various therapeutic dosage combinations along with iron tablets for the Ministry of Health & Family Welfare and for exports. Its product categories include Hormone Products and Herbal Products. Its hormone products include Estradiol Valerate Tablets; Medroxyprogesterone Acetate Tablets; Cabergoline Tablets; Clomiphene Citrate Tablets; Levonorgestrel Tablet; Fluoxymesterone tablets; Liothyronine Sodium tablets; Oxandrolone tablets and others. Its herbal products include Smyle Herbal Toothpaste; Smyle Cough & Sore Throat Reliver and Smyle Mouth Ulcer Gel. Its injectables include Testosterone Cypionate Injection; Methenolone Enanthate Injection; Drostanolone, Testosterone and Trenbolone Inj, and Stanozolol Cypionate Inj.
Read More

Phaarmasia Ltd (523620.BO) Chart

Key Statistics of Phaarmasia Ltd (523620.BO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹89.35₹89.74

Today's Open

₹89.74

Volume

55.00

P/E Ratio (TTM)

-

52 Week Range

₹26.00₹131.75

Market Cap

698.38M

Avg. Volume

402.05

Dividend Yield

-

Financial Metrics & Statements of Phaarmasia Ltd (523620.BO)

Community-Curated Collections with Phaarmasia Ltd (523620.BO) ( With 523620.BO )

View All

Community-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.

FAQ's for Phaarmasia Ltd (523620.BO)

  • According to Musaffa’s Shariah screening methodology, Phaarmasia Ltd (523620.BO) is currently classified as HALAL as of November 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.